![Finn Lyden](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Finn Lyden
Chairman at Vasorum Ltd.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Christopher Cummins | M | - |
Vasorum Ltd.
![]() Vasorum Ltd. Medical SpecialtiesHealth Technology Vasorum Ltd. engages in the research and development of medical equipment. The firm offers Celt ACD, a closure device for cardiology and radiology operations. The company was founded by James Coleman, Christopher Cummins, and Robert Perryman and is headquartered in Leinster, Ireland. | - |
Colin Forde | M | - |
Mirai Medical Ltd.
![]() Mirai Medical Ltd. Information Technology ServicesTechnology Services Mirai Medical Ltd. is an Irish medical technology company that focuses on improving cancer outcomes and enhancing patient experiences. The company is based in Oranmore, Ireland. Mirai Medical has developed a unique precision therapy platform called epore® technology, which targets tumour tissue while preserving surrounding healthy tissue structure. This technique greatly reduces side effects and improves the experience of cancer patients. Mirai Medical's epore® and endove® therapies are approved for commercialization in certain countries and are designed to provide safe and highly effective treatment of skin and gastrointestinal cancers. The company was founded in 2015 by Declan Soden, who has been the CEO since then. | 7 years |
James Coleman | M | - |
Vasorum Ltd.
![]() Vasorum Ltd. Medical SpecialtiesHealth Technology Vasorum Ltd. engages in the research and development of medical equipment. The firm offers Celt ACD, a closure device for cardiology and radiology operations. The company was founded by James Coleman, Christopher Cummins, and Robert Perryman and is headquartered in Leinster, Ireland. | - |
Declan Soden | M | - |
Mirai Medical Ltd.
![]() Mirai Medical Ltd. Information Technology ServicesTechnology Services Mirai Medical Ltd. is an Irish medical technology company that focuses on improving cancer outcomes and enhancing patient experiences. The company is based in Oranmore, Ireland. Mirai Medical has developed a unique precision therapy platform called epore® technology, which targets tumour tissue while preserving surrounding healthy tissue structure. This technique greatly reduces side effects and improves the experience of cancer patients. Mirai Medical's epore® and endove® therapies are approved for commercialization in certain countries and are designed to provide safe and highly effective treatment of skin and gastrointestinal cancers. The company was founded in 2015 by Declan Soden, who has been the CEO since then. | 9 years |
Simon Ombler | M | - |
Mirai Medical Ltd.
![]() Mirai Medical Ltd. Information Technology ServicesTechnology Services Mirai Medical Ltd. is an Irish medical technology company that focuses on improving cancer outcomes and enhancing patient experiences. The company is based in Oranmore, Ireland. Mirai Medical has developed a unique precision therapy platform called epore® technology, which targets tumour tissue while preserving surrounding healthy tissue structure. This technique greatly reduces side effects and improves the experience of cancer patients. Mirai Medical's epore® and endove® therapies are approved for commercialization in certain countries and are designed to provide safe and highly effective treatment of skin and gastrointestinal cancers. The company was founded in 2015 by Declan Soden, who has been the CEO since then. | 7 years |
Charles Taylor | M | - |
Vasorum Ltd.
![]() Vasorum Ltd. Medical SpecialtiesHealth Technology Vasorum Ltd. engages in the research and development of medical equipment. The firm offers Celt ACD, a closure device for cardiology and radiology operations. The company was founded by James Coleman, Christopher Cummins, and Robert Perryman and is headquartered in Leinster, Ireland. | - |
Paddy McDermott | M | - |
Mirai Medical Ltd.
![]() Mirai Medical Ltd. Information Technology ServicesTechnology Services Mirai Medical Ltd. is an Irish medical technology company that focuses on improving cancer outcomes and enhancing patient experiences. The company is based in Oranmore, Ireland. Mirai Medical has developed a unique precision therapy platform called epore® technology, which targets tumour tissue while preserving surrounding healthy tissue structure. This technique greatly reduces side effects and improves the experience of cancer patients. Mirai Medical's epore® and endove® therapies are approved for commercialization in certain countries and are designed to provide safe and highly effective treatment of skin and gastrointestinal cancers. The company was founded in 2015 by Declan Soden, who has been the CEO since then. | - |
Kieran Moynihan | M | - |
Mirai Medical Ltd.
![]() Mirai Medical Ltd. Information Technology ServicesTechnology Services Mirai Medical Ltd. is an Irish medical technology company that focuses on improving cancer outcomes and enhancing patient experiences. The company is based in Oranmore, Ireland. Mirai Medical has developed a unique precision therapy platform called epore® technology, which targets tumour tissue while preserving surrounding healthy tissue structure. This technique greatly reduces side effects and improves the experience of cancer patients. Mirai Medical's epore® and endove® therapies are approved for commercialization in certain countries and are designed to provide safe and highly effective treatment of skin and gastrointestinal cancers. The company was founded in 2015 by Declan Soden, who has been the CEO since then. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
C. Brian Strickland | M | 61 |
Ernst & Whinney
| 2 years |
Mark Belgya | M | 63 |
Ernst & Whinney
| 3 years |
David Robert Styka | M | 62 |
Ernst & Whinney
| - |
Dennis J. Riggs | M | - |
Ernst & Whinney
| 5 years |
Paul Michael Marhan | M | - |
Ernst & Whinney
| 2 years |
Colin Welsh | M | 64 |
Ernst & Whinney
| 4 years |
Maria L. Friedman | F | - |
Ernst & Whinney
| - |
Christopher J. Ziegler | M | - |
Ernst & Whinney
| - |
Robert George Still | M | 68 |
Ernst & Whinney
| - |
Robert Froehlich | M | 71 |
Ernst & Whinney
| 4 years |
Michael Kirk | M | 61 |
Ernst & Whinney
| 3 years |
Hugh A. Neuharth | M | - |
Ernst & Whinney
| - |
Claire Rochat Leonardi | F | - |
Ernst & Whinney
| - |
Gregg Richard Buckbinder | M | 65 |
Ernst & Whinney
| 1 years |
Todd R. Naughton | M | 61 |
Ernst & Whinney
| 2 years |
Michael H. Schoeffler | M | 64 |
Ernst & Whinney
| 4 years |
Theodore H. Emmerich | M | 97 |
Ernst & Whinney
| - |
Kenneth G. Yee | M | 64 |
Ernst & Whinney
| 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
Canada | 18 | 69.23% |
Ireland | 8 | 30.77% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Finn Lyden
- Personal Network